CREATINE has spent decades hiding in the gym, enhancing the workouts of bodybuilders and athletes. But the supplement is now ...
Nine-year follow-up of gene therapy in haemophilia B confirms long-term safety and reduced bleeding, though full capsid ...
For patients with noncardioembolic ischemic stroke or high-risk transient ischemic attack, asundexian, a factor XIa inhibitor, reduced risk for secondary stroke with no excess risk for any bleeding vs ...
A man died after collapsing at work and lying undiscovered for more than an hour after a 999 call was cut off, and ambulance ...
Kite, a Gilead Company , today announced the U.S. Food and Drug Administration (FDA) approved an update to the Yescarta® (axicabtagene ciloleucel) prescribing information removing the previous ...
SAN DIEGO -- Type 2 diabetes patients may have a lower risk of venous thromboembolism (VTE) when treated with a GLP-1 receptor agonist, regardless of their obesity status, a database study involving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results